UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 81

Sortiert nach

Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation

Nature communications, 2017-07, Vol.8 (1), p.98-13, Article 98

2017

Volltextzugriff (PDF)

Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort

The American journal of gastroenterology, 2011-01, Vol.106 (1), p.110-119

2011

Volltextzugriff (PDF)

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account

PloS one, 2016-06, Vol.11 (6), p.e0156666-e0156666

2016

Volltextzugriff (PDF)

Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans

PloS one, 2013-03, Vol.8 (3), p.e59260-e59260

2013

Volltextzugriff (PDF)

Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis

PloS one, 2016-05, Vol.11 (5), p.e0154817-e0154817

2016

Volltextzugriff (PDF)

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases

PloS one, 2017-10, Vol.12 (10), p.e0185193-e0185193

2017

Volltextzugriff (PDF)

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Inflammatory bowel diseases, 2017-07, Vol.23 (7), p.1174-1181

2017

Volltextzugriff (PDF)

Follow-Up of Celiac Disease in Adults: "When, What, Who, and Where"

Nutrients, 2023-04, Vol.15 (9), p.2048

2023

Volltextzugriff (PDF)

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease

PloS one, 2016-05, Vol.11 (5), p.e0155218-e0155218

2016

Volltextzugriff (PDF)

Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti‐tumor necrosis factor agent (CHOOSE TNF TRIAL)

Inflammatory bowel diseases, 2012-08, Vol.18 (8), p.1523-1530

2012

Volltextzugriff (PDF)

Zöliakie

Schweizer Gastroenterologie Gastroentérologie suisse - Gastroenterologia svizzera, 2021-04, Vol.2 (1), p.16-23

2021

Volltextzugriff (PDF)

Because I’m happy – positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort study

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231179335-17562848231179335

2023

Volltextzugriff (PDF)

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort

PloS one, 2016-07, Vol.11 (7), p.e0160215-e0160215

2016

Volltextzugriff (PDF)

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease

Journal of pediatric gastroenterology and nutrition, 2017-08, Vol.65 (2), p.200-206

2017

Volltextzugriff (PDF)

Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa

Inflammatory intestinal diseases, 2021-05, Vol.6 (2), p.87-100

2021

Volltextzugriff (PDF)

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients

Therapeutic advances in gastroenterology, 2018-01, Vol.11, p.1756283X18757715-1756283X18757715

2018

Volltextzugriff (PDF)

The Stability and Anti-apoptotic Function of A1 Are Controlled by Its C Terminus

The Journal of biological chemistry, 2006-05, Vol.281 (19), p.13663-13671

2006

Volltextzugriff (PDF)

Diagnostik und Therapie des Kolonkarzinoms

Schweizer Gastroenterologie Gastroentérologie suisse - Gastroenterologia svizzera, 2022-12, Vol.3 (4), p.130-143

2022

Volltextzugriff (PDF)

The Search for Causative Environmental Factors in Inflammatory Bowel Disease

Digestive diseases (Basel), 2016-01, Vol.34 (1), p.48-55

2016

Volltextzugriff (PDF)

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors

Case reports in gastroenterology, 2015-04, Vol.9 (1), p.106-112

2015

Volltextzugriff (PDF)

Microbial network disturbances in relapsing refractory Crohn's disease

Nature medicine, 2019-02, Vol.25 (2), p.323-336

2019

Volltextzugriff (PDF)

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease

The New England journal of medicine, 2021-07, Vol.385 (1), p.35-45

2021

Volltextzugriff (PDF)

Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH

Inflammatory bowel diseases, 2014-09, Vol.20 (9), p.1496-1501

2014

Volltextzugriff (PDF)

Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations

Digestion, 2020-09, Vol.101 (Suppl 1), p.83-97

2020

Volltextzugriff (PDF)

Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort Study

Journal of gastrointestinal and liver diseases : JGLD, 2023-12, Vol.32 (4), p.460-468

2023

Volltextzugriff (PDF)

1 – 25 von 81

Suche als RSS-Feed

Aktive Filter

KollektionElsevier ScienceDirect Journals Complete

Zeitschrift / SerieJournal Of Crohn's And Colitis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(74)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hypoxia ameliorates intestinal inflammation through NLRP3/mTOR downregulation and autophagy activation

Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account

Smoking cessation induces profound changes in the composition of the intestinal microbiota in humans

Bilberry-Derived Anthocyanins Modulate Cytokine Expression in the Intestine of Patients with Ulcerative Colitis

Risk factors for gallstones and kidney stones in a cohort of patients with inflammatory bowel diseases

Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study

Follow-Up of Celiac Disease in Adults: "When, What, Who, and Where"

The Impact of Azathioprine-Associated Lymphopenia on the Onset of Opportunistic Infections in Patients with Inflammatory Bowel Disease

Systematic assessment of factors influencing preferences of crohn's disease patients in selecting an anti‐tumor necrosis factor agent (CHOOSE TNF TRIAL)

Zöliakie

Because I’m happy – positive affect and its predictive value for future disease activity in patients with inflammatory bowel diseases: a retrospective cohort study

Genotype-Phenotype Associations of the CD-Associated Single Nucleotide Polymorphism within the Gene Locus Encoding Protein Tyrosine Phosphatase Non-Receptor Type 22 in Patients of the Swiss IBD Cohort

Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease

Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa

Low serum zinc levels predict presence of depression symptoms, but not overall disease outcome, regardless of ATG16L1 genotype in Crohn’s disease patients

The Stability and Anti-apoptotic Function of A1 Are Controlled by Its C Terminus

Diagnostik und Therapie des Kolonkarzinoms

The Search for Causative Environmental Factors in Inflammatory Bowel Disease

New Onset, Aggravation and Recurrence of Crohn's Disease upon Treatment with Three Different Tumor Necrosis Factor Inhibitors

Microbial network disturbances in relapsing refractory Crohn's disease

A Randomized Trial of a Transglutaminase 2 Inhibitor for Celiac Disease

Smoking cessation alters intestinal microbiota: insights from quantitative investigations on human fecal samples using FISH

Therapies in Inflammatory Bowel Disease Patients with Extraintestinal Manifestations

Childlessness in Patients with Inflammatory Bowel Disease - Data from the Prospective Multi-center Swiss IBD Cohort Study

Aktive Filter

Suchergebnisse filtern